Bruce Allan Hay

USPTO Granted Patents = 24 (Patent Applications = 12)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 15(Granted Patents)

Company Filing History:

13 out of 51,907

General Electric Company

patents

8 out of 9

Nammi Therapeutics, Inc.

patents

3 out of 21

Nanopharmaceuticals LLC

patents

Years Active: 2013-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12311010 - Formulated and/or co-formulated liposome compositions containing toll-like receptor('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2025-05-27),

2. 12286403 - Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof (2025-04-29),

3. 12059470 - Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof (2024-08-13),

4. 11896646 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2024-02-13),

5. 11833209 - Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof (2023-12-05),

6. 11801304 - Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof (2023-10-31),

7. 11744874 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2023-09-05),

8. 11723888 - Polymer conjugated thyrointegrin antagonists (2023-08-15),

9. 11679141 - Formulated and/or co-formulated liposome compositions containing toll-like receptor ('TLR') agonist prodrugs useful in the treatment of cancer and methods thereof (2023-06-20),

10. 11186551 - Composition of scalable thyrointegrin antagonists with improved retention in tumors (2021-11-30),

11. 10961204 - Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors (2021-03-30),

12. 10450345 - Method of isolation of polypeptide-aptamer-polymer conjugates (2019-10-22),

13. 9846206 - Systems and methods for magnetic material imaging (2017-12-19),

14. 9827335 - Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents (2017-11-28),

15. 9474810 - Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells (2016-10-25),

Title: The Inventor Bruce Allan Hay: Pioneering Innovations in Niskayuna

Introduction: Bruce Allan Hay is a distinguished inventor based in Niskayuna, NY, known for his groundbreaking contributions to various technological fields.

Latest Patents: Bruce Allan Hay holds several patents in the areas of renewable energy, sustainable materials, and advanced electronics, showcasing his commitment to driving innovation forward.

Career Highlights: With a career spanning over two decades, Bruce Allan Hay has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Bruce Allan Hay has collaborated with top engineers, scientists, and researchers, fostering a culture of creativity and excellence that has led to numerous successful projects.

Conclusion: Bruce Allan Hay's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.